A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

Avoid these weight loss journey pitfalls with our expert tips.

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

Prediabetes can improve without weight loss when fat distribution and metabolic hormones shift in healthier ways. Many people believe that losing weight is the primary way to reduce the risk of ...

A shaky economy, wider adoption of weight-loss medication, and changing tastes seem to conspire against some food makers. A strained economy, the growing number of people on weight-loss drugs and ...

Don’t let missteps throw you off your path to weight loss.

Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year.